Lurasidone

Chemical formula: C₂₈H₃₆N₄O₂S  Molecular mass: 492.676 g/mol  PubChem compound: 213046

Therapeutic indications

Lurasidone is indicated for:

Schizophrenia

Population group: only adults (18 years old or older)

Lurasidone is indicated for the treatment of schizophrenia in adults.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Schizophrenia

Population group: only adolescents (12 years - 18 years old)

Lurasidone is indicated for the treatment of schizophrenia in adolescent aged 13 years and over.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Lurasidone is contraindicated in the following cases:

Strong CYP3A4 inducers

Strong potency CYP3A4 inducers

Grapefruit juice

Grapefruit

Strong CYP3A4 inhibitors

Strong CYP3A4 inhibitors

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2020: LATUDA Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈